Milestone Scientific Inc. (MLSS) Stock Score, Valuation & Financial Research
Milestone Scientific Inc. is in the Healthcare sector and Medical - Instruments & Supplies industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 16/100.
Quick answer for MLSS
Milestone Scientific Inc. currently has a Wall Street Score of 16/100. The stored market price is $0.4. Its financial score is 25/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Milestone Scientific Inc. does
Milestone Scientific Inc. is dedicated to the innovation, refinement, and global distribution of advanced diagnostic and therapeutic injection technologies and devices. These solutions cater to the medical, dental, and cosmetic industries, with a presence in the United States, China, and other international markets. The company's operations are divided into two main segments: Dental and Medical. Within its Dental division, key products include CompuDent and the STA Single Tooth Anesthesia System, both instrumental for delivering local anesthetics across all dental procedures. For broader applications, the firm offers CompuFlo, a sophisticated computer-controlled system capable of delivering drugs, anesthetics, and other medicaments comfortably and precisely, as well as aspirating bodily fluids or prior injections. Complementing this, a disposable injection handpiece provides precise tact
MLSS financial snapshot
- Wall Street Score:
- 16/100
- Current price:
- $0.4
- Market capitalization:
- $35.4M
- Revenue:
- $9.4M
- Net income:
- $-4.1M
- Free cash flow:
- $-2.9M
- Cash:
- $2.1M
- Total debt:
- $616K
- EPS:
- -0.05
- Financial score:
- 25/100
- Valuation score:
- 0/100
- Revenue score:
- 7/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $-2.9M, showing cash burn in the current stored period.
- The balance sheet shows $2.1M of cash versus $616K of total debt, leaving more cash than debt.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 25/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-07.
How to research MLSS
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.